Hydroquinone and its analogues in dermatology - a potential health risk.
about
Heterogeneous Pathology of Melasma and Its Clinical ImplicationsTyrosinase inhibitors: a patent review (2011-2015)Hydroquinone and its analogues in dermatology - a risk-benefit viewpointDeoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against Melanosomes[Melasma : An update on the clinical picture, treatment, and prevention].Case report: Hydroquinone and/or glutaraldehyde induced acute myeloid leukaemia?Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disordersSchinus terebinthifolius Raddi extract and linoleic acid from Passiflora edulis synergistically decrease melanin synthesis in B16 cells and reconstituted epidermis.Exogenous ochronosis - successful outcome after treatment with Q-switched Nd:YAG laser.Facial hyperpigmentation: causes and treatment.Melasma: clinical diagnosis and management options.Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser.Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?Hydroquinone, a benzene metabolite, and leukemia: a case report and review of the literature.Cosmetic applications of glucitol-core containing gallotannins from a proprietary phenolic-enriched red maple (Acer rubrum) leaves extract: inhibition of melanogenesis via down-regulation of tyrosinase and melanogenic gene expression in B16F10 melanSkin-lightening effects of a new face care product in patients with melasma.Provoking factors, including chemicals, in Dutch patients with vitiligo.Disposition of [(14)C]hydroquinone in Harlan Sprague-Dawley rats and B6C3F1/N mice: species and route comparison.Synergistic Promotion on Tyrosinase Inhibition by Antioxidants.
P2860
Q26744829-D4B6C719-BEDE-42D9-9E9A-4AB32AC2EB73Q28272557-732D5E59-D775-4D86-9BCA-B437B6361D21Q28279624-A4ED031E-06AE-42AC-A05E-BEF404C9FEE6Q28552914-6CE816E9-7E14-450A-AC51-5298FBF73819Q30239038-DD19DCA6-D6B5-48C4-8BD4-FD1EFD1613D9Q33251987-782CBE6B-3AA4-459F-9548-1B2F373B9997Q33998847-246C5B6E-7B5C-443D-9191-2380D8CDD4C3Q34318672-65D7457D-DC02-4DD5-92FD-3254310324F6Q34610109-A0C0DEF8-138A-4906-8617-22C400CA37D6Q35010478-6A7FCD48-8752-490F-897B-DBDFFA14925BQ35574147-0898705F-3720-4414-AAEC-5DC40C2FAC5AQ35911937-BC77E43E-E812-473E-BDCA-1344DCF690CEQ37679966-DAA87B9D-7EC6-4ECB-9B0D-ADCEE709792AQ37867857-FEFCF10A-7305-482C-83E9-52C00EA8CDC3Q38913933-52F0223F-9D7F-4863-A1B6-22B9E7AAC070Q39832928-018F46FC-1BB1-4353-9F38-49072129B0B1Q44071867-7887B56E-CD82-4E35-ADD2-DBD92EB93472Q46255908-5DBFAC3D-0773-4617-A3C3-26542F99764DQ48310652-6786D1B1-6E05-4ACF-9483-CD2364F20A60
P2860
Hydroquinone and its analogues in dermatology - a potential health risk.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Hydroquinone and its analogues in dermatology - a potential health risk.
@en
Hydroquinone and its analogues in dermatology - a potential health risk.
@nl
type
label
Hydroquinone and its analogues in dermatology - a potential health risk.
@en
Hydroquinone and its analogues in dermatology - a potential health risk.
@nl
prefLabel
Hydroquinone and its analogues in dermatology - a potential health risk.
@en
Hydroquinone and its analogues in dermatology - a potential health risk.
@nl
P2860
P1476
Hydroquinone and its analogues in dermatology - a potential health risk.
@en
P2093
Kooyers TJ
Westerhof W
P2860
P356
10.1111/J.1473-2165.2005.40202.X
P577
2005-06-01T00:00:00Z